GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xiamen Amoytop Biotech Co Ltd (SHSE:688278) » Definitions » Gross-Profit-to-Asset %

Xiamen Amoytop Biotech Co (SHSE:688278) Gross-Profit-to-Asset % : 80.57% (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Xiamen Amoytop Biotech Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Xiamen Amoytop Biotech Co's annualized Gross Profit for the quarter that ended in Mar. 2025 was ¥2,510 Mil. Xiamen Amoytop Biotech Co's average Total Assets over the quarter that ended in Mar. 2025 was ¥3,115 Mil. Therefore, Xiamen Amoytop Biotech Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 80.57%.


Xiamen Amoytop Biotech Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Xiamen Amoytop Biotech Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xiamen Amoytop Biotech Co Gross-Profit-to-Asset % Chart

Xiamen Amoytop Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only 71.23 76.63 85.01 95.02 97.43

Xiamen Amoytop Biotech Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 84.89 99.89 112.25 112.86 80.57

Competitive Comparison of Xiamen Amoytop Biotech Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Xiamen Amoytop Biotech Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xiamen Amoytop Biotech Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xiamen Amoytop Biotech Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Xiamen Amoytop Biotech Co's Gross-Profit-to-Asset % falls into.


;
;

Xiamen Amoytop Biotech Co Gross-Profit-to-Asset % Calculation

Xiamen Amoytop Biotech Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=2633.647/( (2356.087+3050.415)/ 2 )
=2633.647/2703.251
=97.43 %

Xiamen Amoytop Biotech Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=2509.524/( (3050.415+3179.124)/ 2 )
=2509.524/3114.7695
=80.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Xiamen Amoytop Biotech Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Xiamen Amoytop Biotech Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Xiamen Amoytop Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No.330 Wengjiao Road, Xinyang Industry Zone of Haicang, Fujian, Xiamen, CHN, 361022
Xiamen Amoytop Biotech Co Ltd operates as a drug development company. The Company develops and sells protein drugs, interferon drugs, and other products.
Executives
Lan Chun Director
Wang Jun Ye Director

Xiamen Amoytop Biotech Co Headlines

No Headlines